<DOC>
	<DOC>NCT01181479</DOC>
	<brief_summary>The purpose of the study is to evaluate the efficacy and safety of a low dose transdermal contraceptive delivery system containing ethinyl estradiol and levonorgestrel.</brief_summary>
	<brief_title>Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System</brief_title>
	<detailed_description>Comparative evaluation of AG200-15 versus OC with regard to safety, contraceptive efficacy, cycle control (bleeding pattern), subject compliance and serum concentrations of EE and LNG. To evaluate TCDS wearability (including adhesion).</detailed_description>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy females 17(in states where the legal age of consent to receive contraceptives is 17)40 years Regular, consistent menstrual cycles between 25 and 35 days Sexually active women requesting birth control In good general health, confirmed by medical history, physical (including gynecologic) examination and screening laboratory values Known or suspected pregnancy; Lactating women Significant skin reaction to transdermal preparations or sensitivity to surgical / medical tape Any disease that may worsen under hormonal treatment (cardiovascular, liver, metabolic) Use of other contraceptive methods than study medication</criteria>
	<gender>Female</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Contraceptive</keyword>
</DOC>